2 Growth Stocks to Buy With Less Than $100
With e-commerce accounting for just 16% of U.S. retail sales, Shopify has plenty of runway ahead. Exelixis is an innovative drugmaker focusing on one of the most competitive areas in the industry.
Here's Why Exelixis (EXEL) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Exelixis (EXEL) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
EXEL vs. CSLLY: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Exelixis (EXEL) or CSL Limited Sponsored ADR (CSLLY). But which of these two stocks is more attractive to value investors?
Why Exelixis (EXEL) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
5 Top-Ranked Value Stocks With Discounted PEG Ratio to Buy
Five PEG-based stocks that fulfill our screening criteria are Genpact, MPLX, Exelixis, Paramount Global and H&R Block.
Why Exelixis (EXEL) Might be Well Poised for a Surge
Exelixis (EXEL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Exelixis Earnings Drive Share Growth
Oncology company Exelixis, Inc. (EXEL) reported better-than-expected results, driving big share gains.
3 Stocks to Buy for a Soft Landing, If There Is One
Recent economic data is reigniting talk about a soft landing for the economy. That means that the Federal Reserve's monetary policy regarding interest rates is neither too restrictive nor too loose.
4 Best Defensive Stocks For A Potential Soft Landing (SA Quant)
Investors are seeking stability amid the global market selloff in early August, sparked by weak jobs data and fears of an emergency interest rate cut by the Fed. Recession fears were ignited after the yield curve uninverted to cause speculation that the Fed could begin rate cuts in September. With many investors on the defense, and seeking safe-haven investments, staples, healthcare, and utilities have outperformed the market during six of the last seven U.S. recessions.
EXEL or CSLLY: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Exelixis (EXEL) and CSL Limited Sponsored ADR (CSLLY). But which of these two stocks is more attractive to value investors?
